358 related articles for article (PubMed ID: 24091847)
1. [Old problems and new strategies in the fight against pertussis].
Carlino C; Zaratti L; Franco E
Ig Sanita Pubbl; 2013; 69(4):473-80. PubMed ID: 24091847
[TBL] [Abstract][Full Text] [Related]
2. Acellular pertussis vaccine use in risk groups (adolescents, pregnant women, newborns and health care workers): a review of evidences and recommendations.
Bechini A; Tiscione E; Boccalini S; Levi M; Bonanni P
Vaccine; 2012 Jul; 30(35):5179-90. PubMed ID: 22709953
[TBL] [Abstract][Full Text] [Related]
3. [Time for booster doses against whooping cough for 10-year-old children].
Carlsson RM; Ekholm L; Gothefors L; Granström M; Trolin I; Tegnell A
Lakartidningen; 2005 Aug 29-Sep 4; 102(35):2394-8. PubMed ID: 16184889
[TBL] [Abstract][Full Text] [Related]
4. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
America Academy of Pediatrics Commitee on Infectious Diseases
Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
[TBL] [Abstract][Full Text] [Related]
5. [Assessment of postvaccinal response in children past pertussis].
Grzybowska K; Przybyszewski M; Banasik M; Płaneta-Małecka I; Zeman K
Wiad Lek; 2006; 59(11-12):819-22. PubMed ID: 17427498
[TBL] [Abstract][Full Text] [Related]
6. [Whooping cough in Spain. Current epidemiology, prevention and control strategies. Recommendations by the Pertussis Working Group].
Campins M; Moreno-Pérez D; Gil-de Miguel A; González-Romo F; Moraga-Llop FA; Arístegui-Fernández J; Goncé-Mellgren A; Bayas JM; Salleras-Sanmartí L
Enferm Infecc Microbiol Clin; 2013 Apr; 31(4):240-53. PubMed ID: 23411362
[TBL] [Abstract][Full Text] [Related]
7. Whooping cough, twenty years from acellular vaccines introduction.
Greco D; Esposito S; Tozzi A; Pandolfi E; Icardi G; Giammanco A
Ann Ig; 2015; 27(2):415-31. PubMed ID: 26051141
[TBL] [Abstract][Full Text] [Related]
8. Tetanus-diphtheria-acellular pertussis vaccination of adults in the USA.
Gidengil CA; Sandora TJ; Lee GM
Expert Rev Vaccines; 2008 Jul; 7(5):621-34. PubMed ID: 18564017
[TBL] [Abstract][Full Text] [Related]
9. Update on adolescent immunization: review of pertussis and the efficacy, safety, and clinical use of vaccines that contain tetanus-diphtheria-acellular pertussis.
Wilson TR
J Pediatr Health Care; 2006; 20(4):229-37. PubMed ID: 16831630
[TBL] [Abstract][Full Text] [Related]
10. Protecting Newborns Against Pertussis: Treatment and Prevention Strategies.
Salim AM; Liang Y; Kilgore PE
Paediatr Drugs; 2015 Dec; 17(6):425-41. PubMed ID: 26542059
[TBL] [Abstract][Full Text] [Related]
11. Pertussis immunization in the global pertussis initiative international region: recommended strategies and implementation considerations.
Forsyth K; Nagai M; Lepetic A; Trindade E
Pediatr Infect Dis J; 2005 May; 24(5 Suppl):S93-7. PubMed ID: 15876935
[TBL] [Abstract][Full Text] [Related]
12. Use of mass Tdap vaccination to control an outbreak of pertussis in a high school--Cook County, Illinois, September 2006-January 2007.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2008 Jul; 57(29):796-9. PubMed ID: 18650787
[TBL] [Abstract][Full Text] [Related]
13. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.
Bisgard KM; Rhodes P; Connelly BL; Bi D; Hahn C; Patrick S; Glodé MP; Ehresmann KR;
Pediatrics; 2005 Aug; 116(2):e285-94. PubMed ID: 16061582
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age.
Gustafsson L; Hessel L; Storsaeter J; Olin P
Pediatrics; 2006 Sep; 118(3):978-84. PubMed ID: 16950988
[TBL] [Abstract][Full Text] [Related]
15. Pertussis in adolescents and adults: should we vaccinate?
Lee GM; Lebaron C; Murphy TV; Lett S; Schauer S; Lieu TA
Pediatrics; 2005 Jun; 115(6):1675-84. PubMed ID: 15930232
[TBL] [Abstract][Full Text] [Related]
16. Re-emergence of diphtheria and pertussis: implications for Nigeria.
Sadoh AE; Oladokun RE
Vaccine; 2012 Nov; 30(50):7221-8. PubMed ID: 23102975
[TBL] [Abstract][Full Text] [Related]
17. Using computer simulations to compare pertussis vaccination strategies in Australia.
Hethcote HW; Horby P; McIntyre P
Vaccine; 2004 Jun; 22(17-18):2181-91. PubMed ID: 15149775
[TBL] [Abstract][Full Text] [Related]
18. Rationale for use of Tdap booster vaccines for adolescent immunization: overview of efficacy, safety, and clinical use.
Hitchcock WP
Clin Pediatr (Phila); 2006 Nov; 45(9):785-94. PubMed ID: 17041165
[TBL] [Abstract][Full Text] [Related]
19. A modelling analysis of pertussis transmission and vaccination in Rio de Janeiro, Brazil.
Luz PM; Codeço CT; Werneck GL; Struchiner CJ
Epidemiol Infect; 2006 Aug; 134(4):850-62. PubMed ID: 16316489
[TBL] [Abstract][Full Text] [Related]
20. California pertussis epidemic, 2010.
Winter K; Harriman K; Zipprich J; Schechter R; Talarico J; Watt J; Chavez G
J Pediatr; 2012 Dec; 161(6):1091-6. PubMed ID: 22819634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]